Cytosine arabinoside (Ara‐C) plus alpha‐interferon (αIFN) determine prolonged complete remissions in patients with aggressive non‐Hodgkin's lymphoma partially responsive to first‐line doxorubicin‐containing regimens
- 1 October 1994
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 88 (2) , 421-423
Abstract
Summary. Ten patients with aggressive NHL who failed to achieve a complete remission with first‐line chemotherapy were treated with Ara‐C and αIFN. Ara‐C was administered subcutaneously at 100mg on day 1, 150mg on day 2 and 200 mg on days 3,4 and 5 of a 28 d cycle; αIFN was given at 3 million International Units three times a week and continued for 2 years in CR patients. Six CR were attained with a median duration of 36+ months. Toxicity was mild. A new approach to second‐line therapy for aggressive NHL is proposed.Keywords
This publication has 9 references indexed in Scilit:
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's LymphomaNew England Journal of Medicine, 1992
- Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.Journal of Clinical Oncology, 1992
- Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot studyBritish Journal of Haematology, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Clinical pharmacology of low-dose cytosine arabinosideBlood, 1985
- Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patientsCancer, 1985